Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Hemangiosarcoma × Paclitaxel × Clear all

Phase

Status

Completed 2 Withdrawn 1 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 57 Breast Neoplasms 44 Ovarian Neoplasms 36 Lung Neoplasms 20 Neoplasms 17 Fallopian Tube Neoplasms 15 Carcinoma, Ovarian Epithelial 15 Neoplasm Metastasis 13 Head and Neck Neoplasms 8 Adenocarcinoma of Lung 8 Recurrence 7 Uterine Cervical Neoplasms 6 Stomach Neoplasms 6 Endometrial Neoplasms 6 Triple Negative Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Pancreatic Neoplasms 5 Esophageal Neoplasms 5 Uterine Neoplasms 4 Urinary Bladder Neoplasms 4 Solid Tumors 4 Small Cell Lung Carcinoma 4 Prostatic Neoplasms 4 Adenocarcinoma, Bronchiolo-Alveolar 4 Adenocarcinoma Of Esophagus 4 Solid Tumor 3 Esophageal Squamous Cell Carcinoma 3 Carcinoma, Squamous Cell 3 Carcinoma 3 Brenner Tumor 3

Interventions

Doxorubicin 2 sintilimab 1 pazopanib 1 Trabectedin 1 TTI-621 1 Paclitaxel 1 Cyproheptadine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02212015 2022-03-22

EVA

Heidelberg University

Phase 2 Terminated

26 enrolled 16 charts

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡